Epidemiology's contributions to a Nobel prize recognition

Epidemiology

Volumn 20, Issue 5, 2009, Pages 632-634

  Franco, Eduardo L ^a   Olsen, Jorn ^b   Saracci, Rodolfo ^c   Detels, Roger ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AWARDS AND PRIZES; CANCER RISK; CAUSAL ATTRIBUTION; CHOLERA; CIGARETTE SMOKING; DECISION MAKING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; MORTALITY; NOTE; PRIORITY JOURNAL; SCIENTIST; SEXUAL BEHAVIOR; TUBERCULOSIS; UTERINE CERVIX CANCER; VIBRIO CHOLERAE; WART VIRUS;

EPIDEMIOLOGIC STUDIES; EPIDEMIOLOGY; NOBEL PRIZE;

EID: 69549103790     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181afede2     Document Type: Note

References (23)

1. http://nobelprize.org/nobel-prizes/medicine/laureates/2008/press.html. Accessed January 9, 2009.
2. Wynder EL, Cornfield J, Schroff PD, Doraiswami KR. A study of environmental factors in carcinoma of the cervix. Am J Obstet Gynecol. 1954;68:1016-1047.
3. zur Hausen H. Human papilloma viruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol. 1977;78:1-30.
4. Rotkin ID. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res. 1973;33:1353-1367.
5. Beral V. Cancer of the cervix: a sexually transmitted infection? Lancet. 1974;1:1037-1040.
6. Franco EL. Viral etiology of cervical cancer: a critique of the evidence. Rev Infect Dis. 1991;13:1195-1206.
7. Franco EL. The sexually transmitted disease model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection. Epidemiology. 1991;2:98-106.
8. Schiffman MH, Schatzkin A. Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res. 1994;54:1944-1947. (Pubitemid 24132152)
9. Tidy JA, Parry GC, Ward P, et al. High rate of human papillomavirus type 16 infection in cytologically normal cervices. Lancet. 1989;1:434. (Pubitemid 19059168)
10. Tidy J, Farrell PJ. Retraction: human papillomavirus subtype 16b. Lancet. 1989;2:1535. (Pubitemid 20018200)
11. Dyson N, Howley PM, Münger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934-937. (Pubitemid 19066153)
12. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63:1129-1136. (Pubitemid 120035062)
13. Muñoz N, Bosch FX, de Sanjosé S, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992;52:743-749.
14. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327:1272-1278.
15. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85:958-964.
16. Muñoz N, Bosch FX, de Sanjosé S, Shah KV. The role of HPV in the etiology of cervical cancer. Mutat Res. 1994;305:293-301. (Pubitemid 24082905)
17. Kjaer SK, van den Brule AJ, Bock JE, et al. Human papillomavirus - the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer. 1996;65:601-606. (Pubitemid 26092288)
18. Liaw KL, Glass AG, Manos MM, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst. 1999;91:954-960.
19. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000;92:464-474. (Pubitemid 30182883)
20. Muñoz N, Bosch FX, de Sanjosé S, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527.
21. IARC Working Group. Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol.64. Lyon: International Agency for Research on Cancer; 1995.
22. zur Hausen H. Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer. J Natl Cancer Inst. 2001;93:252-253. (Pubitemid 32219803)
23. Bosch FX, Muñoz N, de Sanjosé S, et al. Re: Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer. J Natl Cancer Inst. 2001;93:1349-1350. (Pubitemid 32910578)